Epoetin alfa biosimilar - Intas BioPharmaceuticalsAlternative Names: Epofit; Erykine; Renocel
Latest Information Update: 30 Sep 2013
At a glance
- Originator Intas Biopharmaceuticals
- Class Antianaemics; Recombinant erythropoietins
- Mechanism of Action Erythropoiesis stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaemia
Most Recent Events
- 31 Aug 2005 Launched for Anaemia in India (IV)
- 31 Aug 2005 Launched for Anaemia in India (SC)